AHR director granted 2,594 restricted shares

O'Quinn Marvin R reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

O'Quinn Marvin R reported acquisition or exercise transactions in this Form 4 filing.

American Healthcare REIT, Inc. director Marvin R. O'Quinn received an equity grant of company stock. He was granted 2,594 shares of restricted common stock on June 24, 2026, in connection with his re-election to the board. These restricted shares vest in full on June 24, 2027. Following this award, he directly holds 20,656 shares of common stock. The grant was a compensation-related award at no cash cost to him, rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 2,594 shares

Grant/Award 1 txn

Insider O'Quinn Marvin R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,594	$0.00	$0.00

Holdings After Transaction: Common Stock — 20,656 shares (Direct)

Footnotes (1)

1. F1. Upon his re-election as a director to the board of directors of the Issuer on June 24, 2026, the Reporting Person was granted 2,594 shares of restricted common stock on June 24, 2026. The reported shares of restricted common stock vest on June 24, 2027.

Key Figures

Restricted stock grant: 2,594 shares Post-transaction holdings: 20,656 shares Grant price per share: $0.00 per share +1 more

4 metrics

Restricted stock grant 2,594 shares Restricted common stock granted June 24, 2026

Post-transaction holdings 20,656 shares Total common stock directly held after grant

Grant price per share $0.00 per share Reported transaction price for restricted stock grant

Vesting date June 24, 2027 Vesting date for 2,594 restricted shares

Key Terms

restricted common stock, vest, Grant, award, or other acquisition

3 terms

restricted common stock financial

"the Reporting Person was granted 2,594 shares of restricted common stock"

Restricted common stock is company shares that carry limits on selling or transferring for a set period or until certain conditions are met, like time-based vesting or regulatory clearance. Think of them as shares in a locked box that gradually open; they can become freely tradable later but initially reduce the number of shares available on the market. Investors watch restricted stock because its eventual release can change a company’s share supply, affect stock price, and influence control and dilution.

vest financial

"The reported shares of restricted common stock vest on June 24, 2027."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Grant, award, or other acquisition financial

"transaction code description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did American Healthcare REIT (AHR) report for Marvin R. O'Quinn?

American Healthcare REIT reported that director Marvin R. O'Quinn received a grant of 2,594 shares of restricted common stock. The award was given on June 24, 2026, as part of his compensation upon re-election to the board of directors.

How many shares did Marvin R. O'Quinn acquire in the latest AHR Form 4 filing?

Marvin R. O'Quinn acquired 2,594 shares of restricted common stock. These shares were granted on June 24, 2026, and represent a board compensation award rather than an open-market stock purchase, with a reported price of $0.00 per share.

When do Marvin R. O'Quinn’s newly granted AHR restricted shares vest?

The 2,594 shares of restricted common stock granted to Marvin R. O'Quinn vest on June 24, 2027. Until that vesting date, the shares are restricted stock tied to his continued service as a director on the company’s board.

What is Marvin R. O'Quinn’s total AHR shareholding after this Form 4 transaction?

After the grant, Marvin R. O'Quinn directly holds 20,656 shares of American Healthcare REIT common stock. This total includes the newly awarded 2,594 restricted shares that were granted on June 24, 2026, and are scheduled to vest on June 24, 2027.

Was cash paid for the restricted stock granted to Marvin R. O'Quinn at AHR?

No cash changed hands for this grant; the reported transaction price per share is $0.00. The 2,594 restricted shares represent a non-cash equity compensation award given to Marvin R. O'Quinn upon his re-election to American Healthcare REIT’s board.

Is Marvin R. O'Quinn’s AHR Form 4 transaction an open-market buy or a compensation grant?

The filing describes the transaction as a compensation grant, not an open-market buy. The Form 4 uses code “A” for grant, award, or other acquisition and reports a zero purchase price for the 2,594 restricted common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 05:31 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Quinn Marvin R

(Last) (First) (Middle)

C/O AMERICAN HEALTHCARE REIT, INC.

18191 VON KARMAN AVE., STE. 300

(Street)

IRVINE CALIFORNIA 92612

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/24/2026		A		2,594(1)	A	$0	20,656	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Upon his re-election as a director to the board of directors of the Issuer on June 24, 2026, the Reporting Person was granted 2,594 shares of restricted common stock on June 24, 2026. The reported shares of restricted common stock vest on June 24, 2027.

	/s/ MARVIN R. O'QUINN	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)